MUMBAI, India, July 30 -- Intellectual Property India has published a patent application (202411094952 A) filed by Akums Drugs & Pharmaceuticals Limited on December 02, 2024, for Triple Layer Combination Of Ambroxol, Montelukast And Cetirizine/ Levocetirizine.
Inventor includes Jain Sanjeev.
The application for the patent was published on July 24, 2026, under issue no. 30/2026.
Abstract: The present invention relates to a triple-layer tablet design where Ambroxol SR provides sustained mucolytic action, while Montelukast and Cetirizine or Levocetirizine are formulated as immediate-release layers. This combination ensures that the mucolytic, anti-inflammatory, and antihistaminic effects are delivered at their respective optimal therapeutic timeframes, thereby maximizing patient benefits and treatment efficacy.
Disclaimer: Curated by HT Syndication.
